Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness
Altuna Coy, Antonio
García‑Fontgivell, Joan Francesc
Chacón, Matilde R.
MetadataShow full item record
Background: Conventional clinical biomarkers cannot accurately differentiate indolent from aggressive prostate cancer (PCa). We investigated the usefulness of a biomarker panel measured exclusively in biofluids for assessment of PCa aggressiveness. Methods: We collected biofluid samples (plasma/serum/semen/post-prostatic massage urine) from 98 patients that had undergone radical prostatectomy. Clinical biochemistry was performed and several cytokines/chemokines including soluble(s) TWEAK, sFn14, sCD163, sCXCL5 and sCCL7 were quantified by ELISA in selected biofluids. Also, the expression of KLK2, KLK3, Fn14, CD163, CXCR2 and CCR3 was quantified by real-time PCR in semen cell sediment. Univariate, logistic regression, and receiver operating characteristic (ROC) analyses were used to assess the predictive ability of the selected biomarker panel in conjunction with clinical and metabolic variables for the evaluation of PCa aggressiveness. Results: Total serum levels of prostate-specific antigen (PSA), semen levels of sTWEAK, fasting glycemia and mRNA levels of Fn14, KLK2, CXCR2 and CCR3 in semen cell sediment constituted a panel of markers that was significantly different between patients with less aggressive tumors [International Society of Urological Pathology (ISUP) grade I and II] and those with more aggressive tumors (ISUP grade III, IV and V). ROC curve analysis showed that this panel could be used to correctly classify tumor aggressiveness in 90.9% of patients. Area under the curve (AUC) analysis revealed that this combination was more accurate [AUC = 0.913 95% confidence interval (CI) 0.782-1] than a classical non-invasive selected clinical panel comprising age, tumor clinical stage (T-classification) and total serum PSA (AUC = 0.721 95% CI 0.613-0.830). Conclusions: TWEAK/Fn14 axis in combination with a selected non-invasive biomarker panel, including conventional clinical biochemistry, can improve the predictive power of serum PSA levels and could be used to classify PCa aggressiveness.
Is part ofJournal of Translational Medicine, 2019, vol. 17, ID 307
European research projects
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by (c) Ruiz-Plazas et al., 2019
Showing items related by title, author, creator and subject.
Peñuelas, Josep; Germain i Otzet, Josep; Álvarez Domínguez, Enrique; Aparicio, Enric; Arús i Gorina, Pere; Basnou, Corina; Blanché i Vergés, Cèsar; Bonada i Caparrós, Núria; Canals, Purificació; Capodiferro, Marco; Carceller Roqué, Xavier; Casademunt, Àlex; Casals Missio, Joan; Casals, Pere; Casañas, F. (Francesc); Catalán i Aguilà, Jordi; Checa, Joan; Cordero, Pedro J.; Corominas, Joaquim; Sostoa Fernández, Adolfo de; Espelta Morral, Josep Maria; Estrada i Miyares, Marta; Folch, Ramon; Franquesa, Teresa; Garcia-Lozano, Carla; Garí, Mercè; Geli, Anna M.; González-Guerrero, Óscar; Gordillo, Javier; Gosàlbez i Noguera, Joaquim; Grimalt Obrador, Joan; Guàrdia, Anna; Isern, Rosó; Jordana i Vidal, Jordi; Junqué, Eva; Lascurain i Golferichs, Josep; Lleonart, Jordi; Llorente, Gustavo A.; Lloret, Francisco; Lloret Romañach, Josep; Mallarach, Josep Maria; Martín Vide, Javier; Medir i Huerta, Rosa M.; Melero Cavero, Yolanda; Montasell i Dorda, Josep; Montori, Albert; Munné, Antoni (Munné i Torras); Nel·lo, Oriol; Palazón, Santiago; Palmero, Marina; Parés, Margarida; Pino i Vilalta, Joan; Pintó i Fusalba, Josep; Planagumà, Llorenç; Pons, Xavier; Prat i Fornells, Narcís; Puig i Civera, Carme; Puig Ventosa, Ignasi; Puigdomènech, Pere; Pujol Buxó, Eudald; Roca Pascual, Núria; Rodrigo, Jofre; Rodríguez Teijeiro, José Domingo; Roig i Munar, Francesc Xavier; Romanyà i Socoró, Joan; Rovira, Pere; Sàez, Llorenç; Sauras Yera, Teresa; Serrat, David; Simó, Joan; Soler Insa, Jordi; Terradas, Jaume; Vallejo, V. Ramón (Victoriano Ramón); Vicente, Paloma; Vilaplana, Joan Manuel; Vinyoles Cartanyà, Dolors (MDPI, 2021-02-02)This paper provides an overview of the last 40 years of use, and in many cases abuse, of the natural resources in Catalonia, a country that is representative of European countries in general, and especially those in the ...
Coexpression of p-IGF-1R and MMP-7 modulates panitumumab and cetuximab efficacy in RAS Wild-Type metastatic colorectal cancer patients Alonso, Vicente; Escudero, Pilar; Fernández-Martos, Carlos; Salud Salvia, Maria Antonieta; Méndez, Miguel; Gallego, Javier; Rodriguez, Jose-R.; Martín-Richard, Marta; Fernández-Plana, Julen; Manzano, Hermini; Méndez, José-Carlos; Zanui, Monserrat; Falcó, Esther; Gil-Raga, Mireia; Rojo, Federico; Cuatrecasas, Miriam; Feliu, Jaime; García-Albéniz, Xabier; Maurel, Joan (Elsevier, 2018)INTRODUCTION: The coexpression of pIGF-1R and MMP-7 (double-positive phenotype, DP) correlates with poor overall survival (OS) in KRAS wild-type (WT) (exon 2) metastatic colorectal cancer (mCRC) patients treated with ...
Portero Otín, Manuel; Pamplona Gras, Reinald; Jové Font, Mariona; Rodríguez, M. Mar; Pérez, Daniel; Chaves, Felipe Javier; Esteve, Eduardo; Marin-Garcia, Pablo; Xifra, Gemma; Vendrell, Joan; Ricart, Wifredo; Chacón, Matilde R.; Fernández Real, José Manuel (Nature Publishing Group, 2015)The human intestine is home to a diverse range of bacterial and fungal species, forming an ecological community that contributes to normal physiology and disease susceptibility. Here, the fungal microbiota (mycobiome) in ...